Stereotactic Body Radiation Therapy for Spinal Metastases: A Practical Case-based and Patient-Focused Discussion of the New Standard of Care
Recent publications have established SBRT as the standard of care in painful spine metastases. As a result, spine SBRT is being increasingly utilized in both academic and community practices, rendering this educational activity timely.
Category
  • Central Nervous System
  • SBRT
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Advanced Quantitative Imaging Techniques for Personalized Radiotherapy and Lung Toxicity Avoidance
This activity provides an in-depth exploration of advanced quantitative imaging techniques for personalized radiotherapy, focusing on addressing barriers to clinical implementation and improving the management of lung toxicity.
Category
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Certificate of Attendance
Cost $229.00
Lessons From HyTEC: Brain Necrosis, Optic Neuropathy and Brachial Plexopathy After Stereotactic Radiotherapy
HyTEC (Hypo-fractionated or “Hy”-dose per fraction, Treatment Effects in the Clinic) was an American Association of Physicists in Medicine-led initiative focusing on hypofractionated SBRT/SABR and stereotactic radiosurgery in adults.
Category
  • Central Nervous System
  • SBRT
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Expanding the Scope of Radiation Therapy for Nonmalignant Diseases
This series provides an overview of historical and contemporary indications for radiation therapy in the treatment of nononcological conditions such as ventricular tachycardia, plantar fasciitis, Dupuytren's and Ledderhose diseases, osteoarthritis, and functional brain disorders.
Category
  • Nonmalignant RT
Format
  • onDemand
  • Webinars
Credits
  • 6.50 AMA PRA Category 1 Credit™
  • 6.50 Certificate of Attendance
Cost $449.00
The Role for Consolidative Local Therapy in Stage IV Non-Small Cell Lung Cancer for Oligometastases and Beyond: How are We Improving Outcomes for Patients?
Patients with Stage IV Lung cancer vary in their response to the numerous systemic therapies and are living longer. The role of aggressive local therapy or metastatic directed therapy (MDT) is critical for radiation oncologists and surgeons.
Category
  • Oligometastatic
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Oligometastatic Prostate Cancer: How Far Do We Go?
There have been many advancements in terms of treatment and imaging modalities for patients with oligometastatic prostate cancer. Failure to understand these advancements in treatment options leads to lower quality of care delivered by clinicians treating prostate cancer patients.
Category
  • Genitourinary
  • Oligometastatic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Non-Operative Management in Rectal Cancer Contemporary Practice
Modern treatment options such as radiotherapy dose intensification (EBRT boost, brachytherapy or Papillon technique) or additional chemotherapy in total neoadjuvant therapy for rectal cancers have been shown to improve rectal preservation rates better than ever before.
Category
  • Brachytherapy
  • Gastrointestinal
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Mechanistic Insights and Knowledge Gaps in the Effects of Radiation Therapy on Cardiac Arrhythmias
This paper presents a review of the management of cardiac arrhythmias with radiation including the pathophysiology.
Category
  • Nonmalignant RT
  • Thoracic
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00
Patient Reported Outcomes Following MR-guided Radiotherapy for Prostate Cancer: A Systematic Review and Meta-analysis
In this activity participants will learn how MR-guided radiation therapy impacts patient-reported outcomes in patients with prostate cancer.
Category
  • Genitourinary
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00
Definitive and Salvage Radiation Therapy for Prostate Cancer
Improvements in technique, as well as advances in technology, have resulted in significant survival advances for those with localized and oligometastatic prostate cancer.
Category
  • Genitourinary
Format
  • onDemand
  • Webinars
Credits
  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 Certificate of Attendance
Cost $299.00

Pages